TipRanks
Go Ultimate55% OFF

ChemoMetec A/S (CHY) Stock Price & Analysis

CHY Stock Chart & Stats

€80.60-€1.75(-2.13%)
At close: 5:30 PM GMT+1
EUR 60EUR 70EUR 8029 Jul10 Aug10 Sep14 Sep7 Oct8 Oct28 Oct
Day’s Range
EUR 80.60 - EUR 82.00
52-Week Range
EUR 33.74 - EUR 106.60
Previous Close
EUR 82.35
Volume
0
Average Volume (3M)
1
Market Cap
EUR 1.42B
Enterprise Value
EUR 6.01B
Total Cash (Recent Filing)
EUR 264.74M
Total Debt (Recent Filing)
EUR 7.78M
Price to Earnings (P/E)
52.7
Beta
0.61
Next Earnings
Feb 03, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
1.16%

ChemoMetec A/S News

CHY FAQ

What was ChemoMetec A/S’s price range in the past 12 months?
ChemoMetec A/S lowest stock price was €33.74 and its highest was €106.60 in the past 12 months.
What is ChemoMetec A/S’s market cap?
ChemoMetec A/S’s market cap is €1.42B.
When is ChemoMetec A/S’s upcoming earnings report date?
ChemoMetec A/S’s next earnings report is estimated for Feb 03, 2027 (not yet confirmed), which is in 94 days.
How were ChemoMetec A/S’s earnings last quarter?
ChemoMetec A/S released its earnings results on Sep 10, 2026. The company reported -€0.203 earnings per share for the quarter, missing the consensus estimate of -€0.154 by -€0.049.
Is ChemoMetec A/S overvalued?
According to Wall Street analysts ChemoMetec A/S’s price is currently Overvalued.
Does ChemoMetec A/S pay dividends?
ChemoMetec A/S does not currently pay dividends.
What is ChemoMetec A/S’s EPS estimate?
ChemoMetec A/S’s EPS estimate is 0.87.
How many shares outstanding does ChemoMetec A/S have?
ChemoMetec A/S has 17,402,480 shares outstanding.
What happened to ChemoMetec A/S’s price movement after its last earnings report?
ChemoMetec A/S reported an EPS of -€0.203 in its last earnings report, missing expectations of -€0.154. Following the earnings report the stock price went down -0.659%.
Which hedge fund is a major shareholder of ChemoMetec A/S?
Currently, no hedge funds are holding shares in DE:CHY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology